Latest Stock Advice
Aggressive investors looking at high-risk stocks to invest in should only allocate a small part of their portfolios to those investments
Kinross Gold Corp. reportssoaring results thanks to higher gold prices and cost controls.
Long-term favourite Suncor Energy Inc. has now earmarked a lot of its growing cash flow for shareholders
ResMed Inc. is a leader in the global sleep apnea device market with a near-monopoly in its niche as its total addressable market keeps expanding.
Become a Successful Investor
Here are some of the main types of top Canadian growth stocks—and how to assess which ones offer you the best prospects
Build a retirement investment plan more successfully when you focus on tried and true ways of saving, like using an RRSP and a RRIF, among other strategies
Let me start with a quote I read this week that struck me as worth repeating: “My 2016 New Year’s resolution was to write down three moments of joy before going to bed each night. This simple practice has changed my life. Because no matter what happens each day, I go to bed thinking of something cheerful. Try it.” —Sheryl Sandberg, Facebook Inc.’s chief operating officer, speaking at a University of California at Berkeley 2016 commencement speech, on her personal struggles since the death of her husband in 2015....
A: CarMax, $50.97, symbol KMX on New York (Shares outstanding: 193.8 million; Market cap: $9.8 billion, www.carmax.com), operates 158 auto dealerships in 78 cities and is the largest used car retailer in the U.S. Last year it sold 619,936 vehicles. The company also has one of the largest wholesale vehicle auction businesses in the U.S. In the past year, it sold 394,437 cars and trucks through those on-site events. In the three months ended February 29, 2016, CarMax earned $0.75 a share. Excluding one-time items, that’s up 13.6% from $0.66 a year earlier. Revenue rose 5.5%, to $3.7 billion from $3.5 billion. Last year, the company opened 14 new dealerships and relocated another. In just the latest quarter, it opened five stores—three of them in new markets such as Boston and Peoria/Bloomington, Illinois....
A: Baker Hughes, $47.13, symbol BHI on New York (Shares outstanding: 437.9 million; Market cap: $20.1 billion, www.bakerhughes.com), is the world’s third-largest drilling services and equipment company. Until recently, Baker Hughes was the subject of a $35 billion takeover offer from Halliburton (symbol HAL on New York). However, the deal fell through because of opposition from U.S. and European antitrust regulators. The merger would have brought together the world’s No. 2 and No. 3 oil services companies. That raised concerns about possibly higher prices for oil producers....
A: Aequus Pharmaceuticals Inc., $0.45, symbol AQS on the TSX Venture Exchange (Shares outstanding: 44.9 million; Market cap: $20.2 million, www.aequuspharma.ca), is a Vancouver-based specialty pharmaceutical company. The company’s business model is to acquire or license what it sees as commercial or near-commercial products from drugmakers outside of Canada and then sell them in this country. For example, it hopes to sell Vistitan (bimatoprost 0.03%, ophthalmic solution) in the Canadian market. This product is used to treat some forms of glaucoma and other related eye diseases. Aequus and its partner plan to split the Canadian revenues. The company also aims to develop its own drugs. All of those medications are transdermal versions of existing medications. Transdermal applications of a drug are absorbed slowly through the skin, typically by using an adhesive patch....